During his PhD program in Neuroengineering at Georgia Tech, Jim co-founded Axion Biosystems (acquired by Summa Equity in 2021). Axion was founded to revolutionize the way we capture complex heart and brain activity. Under his leadership as Co-Founder, Director and CTO, Axion Biosystems introduced the groundbreaking Maestro system in 2011, marking the debut of the industry's first high-throughput micro electrode array (MEA) platform. Jim’s expertise includes leading multidisciplinary teams in merging electronics with biology to create user-friendly tools for life science instrumentation, medical diagnostics, and bioelectronic medicine.

‍

With patents in electronically active cell culture assessment and non-invasive diagnostic and therapeutic technologies, his accolades include induction into the Young Alumni Engineering Hall of Fame at Georgia Tech.